These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25526223)

  • 1. Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.
    Wang Y; McAlpine SR
    Org Biomol Chem; 2015 Feb; 13(7):2108-16. PubMed ID: 25526223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
    Wang X; Chen M; Zhou J; Zhang X
    Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.
    Powers MV; Clarke PA; Workman P
    Cancer Cell; 2008 Sep; 14(3):250-62. PubMed ID: 18772114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HSP70: a challenging anti-cancer strategy.
    Goloudina AR; Demidov ON; Garrido C
    Cancer Lett; 2012 Dec; 325(2):117-24. PubMed ID: 22750096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting heat shock proteins in cancer.
    Jego G; Hazoumé A; Seigneuric R; Garrido C
    Cancer Lett; 2013 May; 332(2):275-85. PubMed ID: 21078542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heat shock proteins: new target in cytoprotective and tumor therapy].
    Bao XQ; Liu GT
    Yao Xue Xue Bao; 2008 Mar; 43(3):234-40. PubMed ID: 18630257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.
    Wen W; Liu W; Shao Y; Chen L
    Exp Biol Med (Maywood); 2014 May; 239(5):638-45. PubMed ID: 24676905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors.
    Reikvam H; Nepstad I; Sulen A; Gjertsen BT; Hatfield KJ; Bruserud Ø
    Expert Opin Investig Drugs; 2013 May; 22(5):551-63. PubMed ID: 23586877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazoline Based HSP90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast Cancer Targeting.
    El-Shafey HW; Gomaa RM; El-Messery SM; Goda FE
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127281. PubMed ID: 32527460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone substrate provides missing link for cancer drug discovery.
    Byrd KM; Blagg BSJ
    J Biol Chem; 2018 Feb; 293(7):2381-2382. PubMed ID: 29453286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining an Hsp70 inhibitor with either an N- or C-terminal Hsp90 inhibitor produces mechanistically distinct phenotypes.
    Wang Y; McAlpine SR
    Org Biomol Chem; 2015 Mar; 13(12):3691-8. PubMed ID: 25679754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes.
    Wang Y; McAlpine SR
    Chem Commun (Camb); 2015 Jan; 51(8):1410-3. PubMed ID: 25333923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition.
    Schilling D; Garrido C; Combs SE; Multhoff G
    Cancer Lett; 2017 Apr; 390():146-152. PubMed ID: 28108313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
    Håvik B; Bramham CR
    Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC).
    Jeong CH; Park HB; Jang WJ; Jung SH; Seo YH
    Bioorg Med Chem Lett; 2014 Jan; 24(1):224-7. PubMed ID: 24345447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
    Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
    Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of HSP70 in Cancer and its Exploitation as a Therapeutic Target.
    Martinková V; Trčka F; Vojtěšek B; Müller P
    Klin Onkol; 2018; 31(Suppl 2):46-54. PubMed ID: 31023024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
    Gopalsamy A; Shi M; Golas J; Vogan E; Jacob J; Johnson M; Lee F; Nilakantan R; Petersen R; Svenson K; Chopra R; Tam MS; Wen Y; Ellingboe J; Arndt K; Boschelli F
    J Med Chem; 2008 Feb; 51(3):373-5. PubMed ID: 18197612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
    Cavanaugh A; Juengst B; Sheridan K; Danella JF; Williams H
    Oncotarget; 2015 Nov; 6(37):39821-38. PubMed ID: 26556859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.